| [1] |
Kripke K, Eakle R, Cheng A, Rana S, Torjesen K, Stover J
. The case for prevention - Primary HIV prevention in the era of universal test and treat: a mathematical modeling study. EClinicalMedicine
2022
;
46
:
101347
.
|
| [2] |
Kapiriri L, Lee NM, Wallace LJ, Kwesiga B
. Beyond cost-effectiveness, morbidity and mortality: a comprehensive evaluation of priority setting for HIV programming in Uganda. BMC Public Health
2019
;
19
(
1
):
359
.
|
| [3] |
Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, et al
. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open
2016
;
6
(
3
):
e009656
.
|
| [4] |
Kasaie P, Weir B, Schnure M, Dun C, Pennington J, Teng Y, et al. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective. J Int AIDS Soc 2020;23 Suppl 1(Suppl 1):e25499. http://dx.doi.org/10.1002/jia2.25499.
|
| [5] |
Zhang YR, Wang LL, Jiang Z, Yan HJ, Liu XX, Gu J, et al
. Estimating costs of the HIV comprehensive intervention using the spectrum model - China, 2015-2019. China CDC Wkly
2022
;
4
(
25
):
554
−
9
.
|
| [6] |
The People’s Bank of China. Chart of CNY exchange rate midpoint. http://www.pbc.gov.cn/rmyh/108976/109428/index.html. [2022-6-26]. (in Chinese).
|
| [7] |
Sahu D, Kumar P, Chandra N, Rajan S, Shukla DK, Venkatesh S, et al
. Findings from the 2017 HIV estimation round & trend analysis of key indicators 2010-2017: evidence for prioritising HIV/AIDS programme in India. Indian J Med Res
2020
;
151
(
6
):
562
−
70
.
|
| [8] |
Sundararajan R, Ponticiello M, Nansera D, Jeremiah K, Muyindike W
. Interventions to increase HIV testing uptake in global settings. Curr HIV/AIDS Rep
2022
;
19
(
3
):
184
−
93
.
|
| [9] |
Colvin CJ
. Strategies for engaging men in HIV services. Lancet HIV
2019
;
6
(
3
):
e191
−
200
.
|
| [10] |
Yeh PT, Kennedy CE, Minamitani A, Baggaley R, Shah P, Verster A, et al
. Web-based service provision of HIV, viral hepatitis, and sexually transmitted infection prevention, testing, linkage, and treatment for key populations: systematic review and meta-analysis. J Med Internet Res
2022
;
24
(
12
):
e40150
.
|
| [11] |
Reitsema M, van Hoek AJ, van der Loeff MS, Hoornenborg E, van Sighem A, Wallinga J, et al
. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and
Neisseria gonorrhoeaetransmission and cost-effectiveness. AIDS
2020
;
34
(
4
):
621
−
30
.
|
| [12] |
Celum C, Baeten JM
. Lessons on PrEP from the SEARCH study in east Africa. Lancet HIV
2020
;
7
(
4
):
e219
−
20
.
|
| [13] |
Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, et al
. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS
2018
;
32
(
18
):
2787
−
98
.
|
| [14] |
Jijón S, Molina JM, Costagliola D, Supervie V, Breban R. Can HIV epidemics among MSM be eliminated through participation in preexposure prophylaxis rollouts? AIDS 2021;35(14):2347-54. http://dx.doi.org/10.1097/QAD.0000000000003012.
|
| [15] |
Stover J, Glaubius R, Kassanjee R, Dugdale CM. Updates to the spectrum/AIM model for the UNAIDS 2020 HIV estimates. J Int AIDS Soc 2021;24 Suppl 5(Suppl 5):e25778. http://dx.doi.org/10.1002/jia2.25778.
|